HIV Vaccine Clinical Trial Discontinues
The Global HIV Vaccine Enterprise (the Enterprise), hosted by the International AIDS Society (IAS), has announced the discontinuation of Phase 2b/3 HIV vaccine study ‘HVTN 702’ by the trial sponsor, the National Institute of Allergy and…
Read More...
Read More...